122P首款IL-27靶向抗体Casdozokitug（casdozo，SRF388）作为单药（monotx）或与pembrolizumab（pembro）联合治疗难治性非小细胞肺癌（NSCLC）

{"title":"122P首款IL-27靶向抗体Casdozokitug（casdozo，SRF388）作为单药（monotx）或与pembrolizumab（pembro）联合治疗难治性非小细胞肺癌（NSCLC）","authors":"T.U. Marron, A. Naing, C. Mantia, N. Pennell, H.R. Kim, L. Villaruz, A.B. El-Khoueiry, D.E. Gerber, A. Qin, T-Y. Kim, M. Altan, L. Gandhi, L. J. Appleman, S. Yoon, J. Hill, V. Reichert, R. Masia, L. Harshman, A. Patnaik, D. Morgensztern","doi":"10.1016/j.iotech.2023.100594","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":" 24","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"122P Casdozokitug (casdozo, SRF388), a first-in-class IL-27 targeting antibody, as monotherapy (monotx) or in combination with pembrolizumab (pembro) in treatment-refractory non-small cell lung cancer (NSCLC)\",\"authors\":\"T.U. Marron, A. Naing, C. Mantia, N. Pennell, H.R. Kim, L. Villaruz, A.B. El-Khoueiry, D.E. Gerber, A. Qin, T-Y. Kim, M. Altan, L. Gandhi, L. J. Appleman, S. Yoon, J. Hill, V. Reichert, R. Masia, L. Harshman, A. Patnaik, D. Morgensztern\",\"doi\":\"10.1016/j.iotech.2023.100594\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":192507,\"journal\":{\"name\":\"Immuno-Oncology and Technology\",\"volume\":\" 24\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immuno-Oncology and Technology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.iotech.2023.100594\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immuno-Oncology and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.iotech.2023.100594","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}